Astra Healthcare Launches Pruza-2 Tablets
Astra Healthcare is proud to announce the launch of Pruza-2, our latest Prucalopride 2mg tablets, designed to address chronic constipation in adults. Pruza-2 offers a targeted and effective solution for those suffering from gastrointestinal motility issues.
Why Pruza-2?
The active ingredient, Prucalopride, is a selective serotonin 5-HT4 receptor agonist that stimulates colonic peristalsis, leading to more regular bowel movements and improved quality of life for patients. What sets Pruza-2 apart is its remarkable efficacy and safety profile, making it a trusted option for healthcare professionals treating patients with chronic constipation.
Key Features:
- Rapid Action: Pruza-2 stimulates colonic peristalsis, helping to restore natural bowel movements.
- Proven Efficacy: Clinical trials have shown significant improvements in patients with chronic constipation.
- Safety First: Pruza-2 has been extensively tested to ensure it meets the highest safety standards.
Availability:
The Pruza-2 tablets are now available across pharmacies and healthcare institutions nationwide. Astra Healthcare is committed to providing ongoing support and education to medical professionals on its benefits and usage.
Through this launch, Astra Healthcare continues its mission to bring innovative and accessible healthcare solutions to the market.
For more information, please contact your Astra Healthcare representative or visit our website.